Boehringer Ingelheim Pharma
Boehringer Ingelheim Pharma Pharmaceuticals is a global pharmaceutical manufacturing company. This leading company is one of the global group of companies embracing many cultures and diverse societies. The company aims to improve the health and quality of life of humans and animals is the goal of the research-driven aspects. The main focus of the company is doing so is on conditions for which no satisfactory treatment option exists to date.
It concentrates on developing innovative therapies that can extend people’s lives. It also cares for animal health and stands for advanced prevention for animals. Human health care segment of the company offers effective solutions for different conditions include Cardiovascular, Oncology, Respiratory, Central Nervous System, Metabolic Diseases, and Immunology.
Boehringer Ingelheim Pharma desires to serve mankind by improving human and animal health. The company has its own long history of philanthropy and social responsibility. This company is a family-owned since its founding in 1885. It also feels a special responsibility for its communities and respect for resources. As the company continues to develop breakthrough therapies and healthcare solutions in areas of unmet medical need, access is core to the company’s business and values.
Boehringer Ingelheim Pharma aspires to the sustainable delivery of sound health to humans, animals, and communities around the world by providing unique initiatives, both commercial and philanthropic, based on partnerships and local empowerment.